Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beam Therapeutics (BEAM) Other Non-Current Assets (2019 - 2025)

Beam Therapeutics (BEAM) has disclosed Other Non-Current Assets for 7 consecutive years, with $634000.0 as the latest value for Q4 2025.

  • Quarterly Other Non-Current Assets fell 49.44% to $634000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $634000.0 through Dec 2025, down 49.44% year-over-year, with the annual reading at $634000.0 for FY2025, 49.44% down from the prior year.
  • Other Non-Current Assets for Q4 2025 was $634000.0 at Beam Therapeutics, down from $6.7 million in the prior quarter.
  • The five-year high for Other Non-Current Assets was $15.4 million in Q2 2023, with the low at $634000.0 in Q4 2025.
  • Average Other Non-Current Assets over 5 years is $9.3 million, with a median of $9.3 million recorded in 2023.
  • The sharpest move saw Other Non-Current Assets rose 20.99% in 2023, then plummeted 85.88% in 2025.
  • Over 5 years, Other Non-Current Assets stood at $12.7 million in 2021, then grew by 0.06% to $12.8 million in 2022, then crashed by 31.64% to $8.7 million in 2023, then crashed by 85.62% to $1.3 million in 2024, then tumbled by 49.44% to $634000.0 in 2025.
  • According to Business Quant data, Other Non-Current Assets over the past three periods came in at $634000.0, $6.7 million, and $6.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.